146 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
8
Soluble epoxide hydrolase inhibitors of indolinone alkaloids and phenolic derivatives from Cimicifuga dahurica (Turcz.) Maxim.
Chungnam National University
5
Rational Design of Potent and Selective Inhibitors of an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosa.
University of California
22
Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase.
Chungnam National University
49
N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor¿ Modulators.
Goethe-University Frankfurt
18
1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.
University of California Davis
11
Constituents of the seeds of Cassia tora with inhibitory activity on soluble expoxide hydrolease.
Chungnam National University
36
Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase.
Ehime University
9
Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe.
Chungnam National University
33
Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy.
University of California Davis
9
Identification of N-ethylmethylamine as a novel scaffold for inhibitors of soluble epoxide hydrolase by crystallographic fragment screening.
Astellas Pharma
10
Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.
Sumitomo Dainippon Pharma
33
14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) surrogates: carboxylate modifications.
University of Texas Southwestern Medical Center
18
Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.
Volzhsky Polytechnic Institute (Branch) Volgograd State Technical University
16
Anti-inflammatory components of Euphorbia humifusa Willd.
Chungnam National University
11
Structural insights into binding of inhibitors to soluble epoxide hydrolase gained by fragment screening and X-ray crystallography.
Astellas Pharma
43
Optimization of brain penetrant 11ß-hydroxysteroid dehydrogenase type I inhibitors and in vivo testing in diet-induced obese mice.
AstraZeneca
30
Structure-based optimization of cyclopropyl urea derivatives as potent soluble epoxide hydrolase inhibitors for potential decrease of renal injury without hypotensive action.
Dainippon Sumitomo Pharma
26
Discovery of 1-oxa-4,9-diazaspiro[5.5]undecane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating of chronic kidney diseases.
Toray Industries
30
Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase.
Ehime University
12
Exploring the chemical space of multitarget ligands using aligned self-organizing maps.
Goethe University
37
Discovery of 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating hypertension.
Toray Industries
20
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
University of California
11
Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.
University of California
28
Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase.
Glaxosmithkline
47
Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties.
St. Jude Children'S Research Hospital
8
Synthesis and biological activity of 4-substituted benzoxazolone derivatives as a new class of sEH inhibitors with high anti-inflammatory activity in vivo.
Shanxi Medical University
26
Synthesis and structure-activity relationship studies of novel dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase.
Goethe-University Frankfurt
46
Synthesis and structure-activity relationship of piperidine-derived non-urea soluble epoxide hydrolase inhibitors.
Columbia University
21
Design and synthesis of dual modulators of soluble epoxide hydrolase and peroxisome proliferator-activated receptors.
Zafes/Liff/Osf Goethe-University Frankfurt
4
Evaluation of structure-derived pharmacophore of soluble epoxide hydrolase inhibitors by virtual screening.
Johann Wolfgang Goethe University
11
Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase.
University of California
9
Dual-target virtual screening by pharmacophore elucidation and molecular shape filtering.
TBA
102
Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability.
Colorado State University
7
A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors.
Dainippon Sumitomo Pharma
26
Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagement.
Merck Research Laboratories
52
Orally bioavailable potent soluble epoxide hydrolase inhibitors.
University of California Davis
72
Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase.
Columbia University
46
The structure-activity relationship of urea derivatives as anti-tuberculosis agents.
St. Jude Children'S Research Hospital
24
Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase.
University of California
19
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia.
Arete Therapeutics
42
Incorporation of Piperazino Functionality into 1,3-Disubstituted Urea as the Tertiary Pharmacophore Affording Potent Inhibitors of Soluble Epoxide Hydrolase with Improved Pharmacokinetic Properties
TBA
11
Substituted pyrazoles as novel sEH antagonist: investigation of key binding interactions within the catalytic domain.
Boehringer Ingelheim Pharmaceuticals
52
1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain.
Department of Entomology and University of California Davis Cancer Center
8
Rapid synthesis of an array of trisubstituted urea-based soluble epoxide hydrolase inhibitors facilitated by a novel solid-phase method.
Boehringer Ingelheim Pharmaceuticals
67
Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
Arete Therapeutics
36
Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors.
Merck Research Laboratories
47
Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.
Boehringer Ingelheim Pharmaceuticals
25
Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase.
Boehringer Ingelheim Pharmaceuticals
46
A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors.
Merck Research Laboratories
24
Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase.
Boehringer Ingelheim Pharmaceuticals
49
Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble expoxide hydrolase.
Arete Therapeutics
29
14,15-Epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibition.
University of Texas Southwestern Medical Center
20
Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors.
Merck Research Laboratories
41
Discovery of potent non-urea inhibitors of soluble epoxide hydrolase.
Columbia University
30
Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities.
Department of Entomology and University of California Davis Cancer Center
29
Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors.
Arete Therapeutics
12
Phenyl-benzyl-ureas with pyridazinone motif: Potent soluble epoxide hydrolase inhibitors with enhanced pharmacokinetics and efficacy in a paclitaxel-induced neuropathic pain model.
Gazi University
70
Structure-Based Design and Optimization Lead to the Identification of a Novel Potent sEH Inhibitor with PPARγ Partial Agonist Activity against Inflammatory and Metabolic-Related Diseases.
Shenyang Pharmaceutical University
45
Structure-activity relationship studies and pharmacological evaluation of 4-phenylthiazoles as dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.
California State University
51
Discovery of Phenylacylpiperidine as Novel sEH Inhibitors through Scaffold Hopping of Natural Stilbene.
Beijing Institute of Technology
2
Anti-inflammatory agents design via the fragment hybrid strategy in the discovery of compound c1 for treating ALI and UC.
Wenzhou Medical University
40
Discovery of glycosidated glycyrrhetinic acid derivatives: Natural product-based soluble epoxide hydrolase inhibitors.
Beijing Institute of Technology
31
Redesigning Berberines and Sanguinarines to Target Soluble Epoxide Hydrolase for Enhanced Anti-Inflammatory Efficacy.
Beijing Institute of Technology
21
In Vivo-Active Soluble Epoxide Hydrolase-Targeting PROTACs with Improved Potency and Stability.
Albert Einstein College of Medicine
73
Discovery of Orally Active Phenylquinoline-Based Soluble Epoxide Hydrolase Inhibitors with Anti-Inflammatory and Analgesic Activity.
Beijing Institute of Technology
36
Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors.
Beijing Institute of Technology
27
Design and Synthesis of Dual-Targeting Inhibitors of sEH and HDAC6 for the Treatment of Neuropathic Pain and Lipopolysaccharide-Induced Mortality.
Shenyang Pharmaceutical University
29
1,3-disubstituted ureas functionalized with ether groups are potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic properties.
Department of Entomology and University of California Davis Cancer Center
24
Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator.
Max Planck Institute of Molecular Physiology
14
Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies.
Sichuan University
54
Structure-Directed Discovery of Potent Soluble Epoxide Hydrolase Inhibitors for the Treatment of Inflammatory Diseases.
Shenyang Pharmaceutical University
26
Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis.
University of Salerno
17
Privileged heterocycles for DNA-encoded library design and hit-to-lead optimization.
Chinese Academy of Sciences
22
Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase.
Department of Entomology and University of California Davis Cancer Center
81
Recent Advances in the Medicinal Chemistry of Farnesoid X Receptor.
University of Health Sciences and Pharmacy
44
Recent advancements in the development of heterocyclic anti-inflammatory agents.
Isf College of Pharmacy
18
Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors.
University of California
27
Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist.
Shandong University
75
Peptidyl-urea based inhibitors of soluble epoxide hydrolases.
University of California
47
Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.
University of California
9
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
University of Barcelona (Ub)
59
The Repertoire of Small-Molecule PET Probes for Neuroinflammation Imaging: Challenges and Opportunities beyond TSPO.
Massachusetts General Hospital
19
Synthesis and biological evaluation of new series of benzamide derivatives containing urea moiety as sEH inhibitors.
Shenyang Pharmaceutical University
36
Fragment-to-Lead Medicinal Chemistry Publications in 2020.
Vrije Universiteit Amsterdam
5
Designing a Small Fluorescent Inhibitor to Investigate Soluble Epoxide Hydrolase Engagement in Living Cells.
Goethe University Frankfurt
32
Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility.
Department of Entomology and University of California Davis Cancer Center
83
Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.
Indian Institute of Technology (B.H.U.)
27
Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors:
University Federico Ii of Naples
24
Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors.
Universitat De Barcelona
21
Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.
California State University
52
Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors.
Goethe-University
5
Combined Cardioprotective and Adipocyte Browning Effects Promoted by the Eutomer of Dual sEH/PPARγ Modulator.
Goethe University
28
Second-Generation Dual FXR/sEH Modulators with Optimized Pharmacokinetics.
Goethe University Frankfurt
32
Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.
Shenyang Pharmaceutical University
36
Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.
University of California Davis
26
Discovery of soluble epoxide hydrolase inhibitors through DNA-encoded library technology (ELT).
Gsk
9
QSAR and classification of murine and human soluble epoxide hydrolase inhibition by urea-like compounds.
The Pennsylvania State University
44
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase.
Goethe-University of Frankfurt
22
2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors:
Universitat De Barcelona
6
Machine Learning on DNA-Encoded Libraries: A New Paradigm for Hit Finding.
Google Research Applied Science, Mountain View, California 94043, United States.
8
Identification, characterization, kinetics, and molecular docking of flavonoid constituents from Archidendron clypearia (Jack.) Nielsen leaves and twigs.
Chungnam National University
8
Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative.
Eicosis Human Health
20
Ligand-based optimization to identify novel 2-aminobenzo[d]thiazole derivatives as potent sEH inhibitors with anti-inflammatory effects.
Shenyang Pharmaceutical University
46
Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.
Synthia
25
Bioisosteric substitution of adamantane with bicyclic lipophilic groups improves water solubility of human soluble epoxide hydrolase inhibitors.
University of California Davis
13
Computer-Aided Fragment Growing Strategies to Design Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 Hydrolase.
Goethe-University
7
DNA-Encoded Library Screening as Core Platform Technology in Drug Discovery: Its Synthetic Method Development and Applications in DEL Synthesis.
Daegu-Gyeongbuk Medical Innovation Foundation (Dgmif)
34
Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility.
University of California Davis
22
Challenges of docking in large, flexible and promiscuous binding sites.
The Barcelona Institute For Research In Biomedicine (Irb Barcelona)
5
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
Goethe-University Frankfurt
15
Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.
Universitat De Barcelona
21
Synthesis, Biological Evaluation and Structure-Activity Relationships of Diflapolin Analogues as Dual sEH/FLAP Inhibitors.
University of Innsbruck
4
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome.
University of Chieti "G. D.Annunzio
13
Research progress in the biological activities of 3,4,5-trimethoxycinnamic acid (TMCA) derivatives.
Northwest University
17
Design of Dual Inhibitors of Soluble Epoxide Hydrolase and LTA
Goethe University Frankfurt
2
Computer-Aided Selective Optimization of Side Activities of Talinolol.
Goethe-University of Frankfurt
29
Development of selective tight-binding inhibitors of leukotriene A4 hydrolase.
Scripps Research Institute
22
Structure-based optimization of the piperazino-containing 1,3-disubstituted ureas affording sub-nanomolar inhibitors of soluble epoxide hydrolase.
Chinese Academy of Sciences
8
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis.
University of Perugia Via Del Liceo
3
NMR-Based Investigation of Hydrogen Bonding in a Dihydroanthracen-1(4 H)one from Rubia philippinensis and Its Soluble Epoxide Hydrolase Inhibitory Potential.
Yale University
10
Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology.
Goethe University Frankfurt
11
Inhibition Potential of Cycloartane-Type Glycosides from the Roots of Cimicifuga dahurica against Soluble Epoxide Hydrolase.
Chungnam National University
28
Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
University of California Davis
48
Adamantyl thioureas as soluble epoxide hydrolase inhibitors.
University of California Davis
23
Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain.
University of California Davis
46
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis.
Goethe-University Frankfurt
25
Compounds and compositions useful for treating disorders related to NTRK
Blueprint Medicines
92
N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
Kalvista Pharmaceuticals
11
Orvinol and thevinol derivatives useful in the treatment of anxiety or a compulsive disorder
The University of Bath
93
Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
Amgen
6
Reboxetine: functional inhibition of monoamine transporters and nicotinic acetylcholine receptors.
University of Kentucky
3
Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751.
Shionogi
15
Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior.
Bayer